Using terbium against lymphoma
Villigen, 02.06.2025 — Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by promising results from experiments carried out at the Paul Scherrer Institute PSI in collaboration with Inselspital – Bern University Hospital. The team’s findings are being published today in the Journal of Nuclear Medicine. The researchers are now refining this type of therapy in order to carry out clinical trials.